213 related articles for article (PubMed ID: 35840593)
1. Inhibition of NMDA receptors through a membrane-to-channel path.
Wilcox MR; Nigam A; Glasgow NG; Narangoda C; Phillips MB; Patel DS; Mesbahi-Vasey S; Turcu AL; Vázquez S; Kurnikova MG; Johnson JW
Nat Commun; 2022 Jul; 13(1):4114. PubMed ID: 35840593
[TBL] [Abstract][Full Text] [Related]
2. Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.
Glasgow NG; Povysheva NV; Azofeifa AM; Johnson JW
J Neurosci; 2017 Oct; 37(40):9686-9704. PubMed ID: 28877967
[TBL] [Abstract][Full Text] [Related]
3. Effects of Mg
Glasgow NG; Wilcox MR; Johnson JW
Neuropharmacology; 2018 Jul; 137():344-358. PubMed ID: 29793153
[TBL] [Abstract][Full Text] [Related]
4. Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine.
Emnett CM; Eisenman LN; Taylor AM; Izumi Y; Zorumski CF; Mennerick S
Mol Pharmacol; 2013 Dec; 84(6):935-47. PubMed ID: 24101301
[TBL] [Abstract][Full Text] [Related]
5. 7-Methoxyderivative of tacrine is a 'foot-in-the-door' open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivo.
Kaniakova M; Kleteckova L; Lichnerova K; Holubova K; Skrenkova K; Korinek M; Krusek J; Smejkalova T; Korabecny J; Vales K; Soukup O; Horak M
Neuropharmacology; 2018 Sep; 140():217-232. PubMed ID: 30099049
[TBL] [Abstract][Full Text] [Related]
6. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
Gilling KE; Jatzke C; Hechenberger M; Parsons CG
Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
[TBL] [Abstract][Full Text] [Related]
7. Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg2+ and memantine under conditions of agonist exposure.
McKay S; Bengtson CP; Bading H; Wyllie DJ; Hardingham GE
Neuropharmacology; 2013 Nov; 74():119-25. PubMed ID: 23402996
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of NMDA receptor channel block by MK-801 and memantine.
Song X; Jensen MØ; Jogini V; Stein RA; Lee CH; Mchaourab HS; Shaw DE; Gouaux E
Nature; 2018 Apr; 556(7702):515-519. PubMed ID: 29670280
[TBL] [Abstract][Full Text] [Related]
9. Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.
Kotermanski SE; Johnson JW
J Neurosci; 2009 Mar; 29(9):2774-9. PubMed ID: 19261873
[TBL] [Abstract][Full Text] [Related]
10. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).
Parsons CG; Gruner R; Rozental J; Millar J; Lodge D
Neuropharmacology; 1993 Dec; 32(12):1337-50. PubMed ID: 8152525
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into binding of therapeutic channel blockers in NMDA receptors.
Chou TH; Epstein M; Michalski K; Fine E; Biggin PC; Furukawa H
Nat Struct Mol Biol; 2022 Jun; 29(6):507-518. PubMed ID: 35637422
[TBL] [Abstract][Full Text] [Related]
12. Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones.
Wild AR; Akyol E; Brothwell SL; Kimkool P; Skepper JN; Gibb AJ; Jones S
Neuropharmacology; 2013 Oct; 73():138-46. PubMed ID: 23727219
[TBL] [Abstract][Full Text] [Related]
13. Memantine binding to a superficial site on NMDA receptors contributes to partial trapping.
Kotermanski SE; Wood JT; Johnson JW
J Physiol; 2009 Oct; 587(Pt 19):4589-604. PubMed ID: 19687120
[TBL] [Abstract][Full Text] [Related]
14. [Memantine: a therapeutic drug for Alzheimer's disease and the comparison with MK-801].
Kato T
Nihon Yakurigaku Zasshi; 2004 Sep; 124(3):145-51. PubMed ID: 15333987
[TBL] [Abstract][Full Text] [Related]
15. Tonically active NMDA receptors--a signalling mechanism critical for interneuronal excitability in the CA1 stratum radiatum.
Riebe I; Seth H; Culley G; Dósa Z; Radi S; Strand K; Fröjd V; Hanse E
Eur J Neurosci; 2016 Jan; 43(2):169-78. PubMed ID: 26547631
[TBL] [Abstract][Full Text] [Related]
16. Memantine inhibits [3H]MK-801 binding to human hippocampal NMDA receptors.
Berger W; Deckert J; Hartmann J; Krotzer C; Kornhuber J; Ransmayr G; Heinsen H; Beckmann H; Riederer P
Neuroreport; 1994 Jun; 5(10):1237-40. PubMed ID: 7919173
[TBL] [Abstract][Full Text] [Related]
17. Patch clamp combined with voltage/concentration clamp to determine the kinetics and voltage dependency of N-methyl-D-aspartate (NMDA) receptor open channel blockers.
Parsons CG; Gilling KE
Methods Mol Biol; 2014; 1183():43-63. PubMed ID: 25023301
[TBL] [Abstract][Full Text] [Related]
18. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate receptors amplify activation and aggregation of human platelets.
Kalev-Zylinska ML; Green TN; Morel-Kopp MC; Sun PP; Park YE; Lasham A; During MJ; Ward CM
Thromb Res; 2014 May; 133(5):837-47. PubMed ID: 24593912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
